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Abstract
In a mouse model, in vitro fertilization or extended embryo culture leads to the increased
expression of TRP53 in susceptible embryos. Ablation of the TRP53 gene improved embryo
viability indicating that increased expression of TRP53 is a cause of the reduction of embryo viability
resulting from in vitro fertilization or embryo culture. This study investigates the status of TRP53
expression in human embryos produced by intracytoplasmic sperm injection. Following
fertilization, embryos were cultured for 96 h and then cryopreserved. Immediately upon thawing
they were fixed in formaldehyde and subjected to immunostaining for TRP53. Staining was
visualized by confocal microscopy. Negative controls were incubated with isotype control
immunoglobulin and showed negligible staining. All embryos showed TRP53 staining above negative
controls. TRP53 staining was heterogenous within and between embryos. An embryo that showed
retarded development showed high levels of TRP53 expression. A blastocyst that had a collapsed
blastocoel also showed high levels of TRP53 compared to morphologically normal blastocysts.
Most TRP53 staining was in the region of the nucleus. Morphologically normal blastocysts tended
to show little nuclear accumulation of stain. However, some cells within these embryos had high
levels of nuclear TRP53 expression. The results show that embryos have varying sensitivity to the
stresses of production and culture in vitro, and this resulted in variable expressivity of TRP53.
Background
It is well recognised that a large proportion of embryos
produced by in vitro fertilization (IVF) and cultured in
vitro do not have the capacity to produce viable offspring.
Some studies have examined the patterns of gene expres-
sion in human embryos in vitro to determine whether
expression of any genes is predictive or informative of the
embryo's developmental fate. One such study found an
apparent association between the level of expression of
transformation related protein 53 (TRP53) mRNA and the
normality of embryo morphology [1].
TRP53 mRNA is expressed in human embryos produced
by IVF [1,2]. Its expression was low in oocytes, the zygote
and cleavage stage embryos but showed an approximate
10-fold increase in transcript number at the blastocyst
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stage. A statistically significant association was observed
between the degree of fragmentation of cells and the level
of TRP53 mRNA expression [1], although this association
was highly variable. It was suggested that the overexpres-
sion of TRP53  observed in these fragmenting embryos
may infer increased responses by some embryos to geno-
toxic and/or non-genotoxic stress in vitro [1].
In a mouse model, IVF or extended culture of zygotes
resulted in increased expression of TRP53 protein in the
resulting blastocysts when assessed by western blot analy-
sis or immunolocalization [3,4]. TRP53 staining in these
embryos was higher in the nucleus, and was transcription-
ally active, since it leads to the increased expression of
BAX [3]. The level of TRP53 expression was related to the
rate of development of embryos in vitro and their capacity
for ongoing foetal development, while the deletion of
TRP53 ameliorated some of the adverse effects of embryo
culture [3,4]. There is much anecdotal evidence that trans-
genic over-expression of Trp53 is incompatible with early
mouse embryo development.
A mouse strain (C57BL/6) that showed high levels of
TRP53 following culture had poor embryo viability upon
embryo transfer, compared with a strain (hybrid B6CBF1)
that showed little TRP53 expression following culture.
Furthermore, the increased TRP53 expression that occurs
in MDM2-/- embryos caused the failure of embryo devel-
opment and embryonic lethality [5-7]. In another model,
diabetes-induced early embryopathy was partially amelio-
rated by TRP53 deletion in mice [8]. These lines of evi-
dence show TRP53 expression may be an important
determinant of embryo viability. It was concluded that in
the mouse model the increased expression of TRP53 was
a consequence of unidentified stressors of IVF and culture
and that its expression was one cause of the reduction in
viability and developmental potential by some embryos
produced by IVF subjected to culture [3,4].
The high levels of TRP53 mRNA in some human embryos
produced by IVF [1,2] may suggest that expression of
TRP53 is also a determinant of human embryo viability. It
is noteworthy, however, that TRP53 protein expression is
not primarily regulated at the level of transcription. A
major component of the regulation of protein levels of
TRP53 is by modulation of the half-life of the protein [9].
The MDM2/HDM2 protein binds TRP53 and targets it for
ubiquitin-mediated degradation by the cellular proteo-
some [10,11]. Thus, cellular TRP53 levels are maintained
in a latent state by its continual degradation. A range of
genotoxic and non-genotoxic stressors act to disrupt
MDM2/HDM2 mediated degradation of TRP53, allowing
its rapid accumulation within cells subjected to a range of
stressors. Thus an increase in mRNA levels may not neces-
sarily predict increased TRP53 protein expression in blas-
tocysts.
This study examined the level and cellular localization of
TRP53 expression in human embryos produced by intrac-
ytoplasmic sperm injection (ICSI) followed by culture for
4 days. The results show that TRP53 expression is highly
variable within and between embryos, with some
embryos showing high levels of TRP53 staining. Blasto-
cysts with good morphology tended to show less staining
than those that were retarded or of poor morphology. The
results of this pilot study show that the expression of
TRP53 is highly variable in embryos produced and cul-
tured in vitro.
Methods
A total of 7 embryos from two couples were examined.
Both couples had received treatment for male factor infer-
tility (oligozoospermia; <5 × 106/mL). Embryos were cre-
ated by ICSI, as previously described [12]. Embryos that
were excess to the needs of the treated couples were
donated, with informed consent, under NHMRC licence
309702B. All other procedures were as previously
described [13]. Embryo culture was carried out in the Syd-
ney IVF sequential media suite (Cook Australia Pty Ltd,
Brisbane, Qld, Australia) under low-oxygen conditions
(5% oxygen, 6% carbon dioxide, 89% nitrogen); using
Nunclon four-well dishes (Nunc, Roskilde, Denmark) in
10 μL drops. On day 3 after fertilization, the embryos were
transferred from low-glucose, pyruvate-dominant Sydney
IVF Cleavage Medium (zero glucose, 0.2 mmol/L pyru-
vate) to glucose-dominant Sydney IVF Blastocyst Medium
(3 mmol/L glucose, 0.2 mmol/L pyruvate). Under Austral-
ian legislation, only excess embryos that have been cryop-
reserved are available for research. Embryos not
immediately transferred were incubated in 5% glycerol (v/
v) and then in 9% glycerol (v/v) and 0.2 M sucrose in
preparation for cryopreservation (Sydney IVF Blastocyst
Freezing Kit; Cook). Embryos were placed in straws (IMV
Technologies, France) and loaded into a rate-controlled
freezer (Kryo 10 series II; Planar, Middelsex, England).
Straws were cooled to -7°C at 2°/min, then -7°C to -30°C
at 0.3°/min, and from -30°C to -150°C at 35°/min, then
plunged directly into liquid nitrogen at -196°C. Blasto-
cysts were thawed by removing the straw from the liquid
nitrogen and exposing the straw to room temperature for
30 sec, followed by 30 sec in a 30°C water bath. The straw
was cut open onto a Petri dish and the embryos were then
sequentially passed through buffers containing 1.0 M pro-
panediol followed by 0.5 M propanediol (each with 0.2 M
sucrose) and then into 0.2 M sucrose (Sydney IVF Blasto-
cyst Thawing Kit; Cook). After washing in Hepes buffered
media embryos were immediately fixed in formaldehyde
(2%) and subjected to immunolabelling for TRP53.Reproductive Biology and Endocrinology 2007, 5:39 http://www.rbej.com/content/5/1/39
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Grading of embryos
Upon thawing embryos were assigned a score [14].
Briefly, blastocysts were given a numerical score from 1 to
4 on the basis of their degree of expansion, as follows: 1,
an early blastocyst with a blastocoel that is less than half
of the volume of the embryo; 2, a blastocyst with a blast-
ocoel that is half of or greater than half of the volume of
the embryo; 3, a full blastocyst with a blastocoel com-
pletely filling the embryo; 4, an expanded blastocyst with
a blastocoel volume larger than that of the early embryo,
with a thinning zona. For blastocysts graded as 3 or 4, the
development of the inner cell mass was assessed as fol-
lows: A, tightly packed, many cells; B, loosely grouped,
several cells; or C, very few cells. The trophectoderm was
assessed as follows: A, many cells forming a cohesive epi-
thelium; B, few cells forming a loose epithelium; or C,
very few large cells. The grade is represented as NXY:
where N is blastocyst score; X, inner cell mass score; and
Y, trophectoderm score.
Immunolocalization
Immunolocalization procedures were the same as previ-
ously described for mouse embryos [4]. Briefly, embryos
were washed 3 times in PBS with 0.1% (w/v) BSA, 0.1%
(v/v) Tween-20 and 0.2% (w/v) sodium azide (washing
buffer) and then fixed with freshly prepared 2% parafor-
maldehyde (w/v) (Sigma) in PBS (pH 7.4) for 30 min.
This was followed by permeabilization with 2% parafor-
maldehyde with 0.3% Tween-20 (Sigma) at room temper-
ature for a 30 min. Embryos were washed 3 times in
washing solution and then were blocked in PBS contain-
ing 2% (w/v) BSA, and 30% (v/v) goat serum for 3h. They
were stained overnight at 4°C with primary antibody
1:500 anti-TRP53 (Ab-7) polyclonal antibody (Cat No:
PC35, Oncogene Research Products, Nottingham, NG9
2JR, UK) or an equivalent concentration of isotype control
immunoglobulin (negative control). Primary antibody
was detected by incubation of embryos with secondary
antibody coupled to FITC in PBS, 2% BSA for 1 h at room
temperature. Optical sectioning was performed with a
BioRad Radiance Confocal microscope, using a Nikon
Plan Apo 60X/1.4 oil emersion objective. Images were
captured using Lasersharp 2000, Version 4.0 (BioRad).
Microscope and laser settings were adjusted such that no
fluorescence was observed with nonimmune controls. All
the test specimens were observed with these same settings.
Results
The expression of TRP53 in human embryos was assessed
by immunofluorescence with confocal microscopy. Stain-
ing of 7 human embryos for immunodetectable TRP53
showed considerable within and between embryo hetero-
geneity of TRP53 expression. Figure 1 shows single equa-
torial optical sections through each embryo. Nonimmune
(control) immunoglobulin samples showed no staining
for a blastocyst with some signs of degeneration (embryo
grade 3BB) (Fig 1A–B) or in a morphologically normal
blastocyst (grade 3AA) (Fig 1, 2A–B). Five embryos were
stained for TRP53. Two embryos were graded as 3BA (Fig
1C,D and 2C,D). These blastocyst showed a relatively
high levels of staining in some nuclei of the trophecto-
derm, but this was less apparent in the cells of the inner
cell mass (Fig 1C, 2C). One blastocyst showed extensive
expansion (grade 4AA) and there was little obvious TRP53
staining in this blastocyst (Fig 1E–F). One blastocyst had
either failed to expand or had collapsed (grade 1) (Fig 1,
2E), and it displayed obvious nuclear accumulation of
TRP53 staining in all cells. In a blastocyst with obvious
signs of degeneration (grade < 1) (Fig 1, 2G,H) there was
extensive TRP53 staining throughout the embryo.
The embryos shown in Fig 1, 2G and 2C were recon-
structed by compilation of all z-sections through the
entire embryo shown in (Fig 2A and 2B, respectively). The
images were transformed by pseudocolor representation
of staining of TRP53 intensity. Figure 2A confirms the
extensive staining throughout all cells and shows some
staining in the perivitelline space and zona pellucida in
the degenerating embryo. Figure 2B shows a small
number of cells expressed high levels of TRP53 within the
nuclear region in an otherwise morphologically normal
blastocyst (grade 3BA). There was little evidence of signif-
icant staining within the inner cell mass, while some cells
within the trophectoderm showed marked levels of
nuclear staining.
The results show that human embryos in culture display
variable levels of TRP53 staining, and this variability
existed both within and between embryos. While embryos
of poorest morphology showed the highest level of TRP53
staining, the level of expression within morphologically
normal blastocysts was not predicted by the embryo's
grade.
Discussion
TRP53 is a transcription factor that induces the expression
of a complex transcriptome. It has roles in the regulation
of the rate of cell-cycle progression and the survival or
death of cells [9,11,15]. TRP53 also has a range of actions
that are independent of its transcriptional activities [16].
In normal cells its expression is latent due to its rapid deg-
radation by the proteosome. Changes in the rate of TRP53
degradation can lead to its acute upregulation, and this
commonly occurs as a response of the cell to a range of
genotoxic and non-genotoxic stressors [11,17].
This study shows that within a sample of human embryos
produced by ICSI, two embryos that were morphologi-
cally abnormal displayed high levels of TRP53 staining. In
these embryos TRP53 staining was most intense in theReproductive Biology and Endocrinology 2007, 5:39 http://www.rbej.com/content/5/1/39
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Staining of several embryos from 2 couples (1 & 2) with either nonimmune IgG (1A and 2A) or TRP53 antibody (all other  embryos) Figure 1
Staining of several embryos from 2 couples (1 & 2) with either nonimmune IgG (1A and 2A) or TRP53 antibody (all other 
embryos). Two images of each embryo (except 2C) are provided: an equatorial confocal section (confocal) or phase contrast 
(phase). All confocal images were taken with identical microscope, laser and magnification settings. The position of the inner 
cell mass is identified by a white arrow where applicable. The bar is 10 μm, N.A. is not available.
Couple 1 Couple 2 
confocal phase confocal phase
N.A.
1A 1B
1C 1D
1E 1F
2A 2B
2C 2D
2E 2F
2G 2HReproductive Biology and Endocrinology 2007, 5:39 http://www.rbej.com/content/5/1/39
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region of the nucleus. By comparison all embryos that
formed morphologically normal blastocysts had lower
levels of TRP53 staining. It is noteworthy, however, that
there was variability in expression of TRP53 both within
and between blastocysts of normal morphology. Thus,
some cells in otherwise normal blastocysts showed high
levels of TRP53 staining. However, the blastocyst that had
the highest rating for morphology (grade 4AA) showed
the least TRP53 staining. The high levels of expression of
TRP53 observed in embryos of the poorest morphology is
consistent with the observation that embryos with poorest
morphology expressed the highest levels of TRP53 mRNA
[1].
It is generally accepted that embryos with retarded devel-
opment and those with poor morphology are less likely to
form viable embryos upon transfer to recipients [14,18].
Given the demonstrated role of TRP53 expression in
reducing embryo viability in the mouse model [3,4], the
high rates of TRP53 expression in some human embryos
may well be a cause of this lower developmental poten-
tial. It is not clear from this study whether the expression
of the high levels of TRP53 is a cause or consequence of
the poor development of these embryos.
It is also generally accepted within human ART practice
that many embryos of seemingly normal morphology do
not have the capacity for full development. It was there-
fore of interest to note that some embryos of normal mor-
phology also expressed TRP53. The presence of TRP53 in
some cells of these embryos infers that TRP53 expression
itself does not necessarily induce acute loss of morpholog-
ical normality up to the blastocyst stage, and this is con-
sistent with the observations made in mice [3,4]. In a
mouse model, inbred mice, which are highly susceptible
to the stressors of culture, expressed high levels of TRP53
following culture (even in morphologically normal blast-
ocysts). Yet these blastocysts had low rates of develop-
mental viability following embryo transfer [3]. The
genetic deletion of TRP53 significantly reversed this loss
of viability in cultured embryos [4], arguing that the
upregulation of TRP53 expression in culture is a causative
agent in loss of the embryo's developmental potential
irrespective of embryo morphology.
We choose to examine embryos that were fertilized by
ICSI. This was undertaken with the view that oocytes from
this population were most likely to be without inherent
defects. The process of ICSI itself did not cause increased
TRP53 expression, since several embryos fertilized in this
manner did not show high levels of expression. It is
known that sperm from some men have definable rates of
DNA damage [19]. This study does not address whether
sperm based defects are a causative agent of the expression
Compilation of sequential z-sections through the entire depth of two embryos shown in Fig 1 Figure 2
Compilation of sequential z-sections through the entire depth of two embryos shown in Fig 1. A. compilation of sections from 
embryo shown Fig 1 2G; B. compilation of embryos from Fig1 2C. Greyscale images were converted to pseudocolor represen-
tation of staining intensity (blue lowest intensity, red greatest intensity).
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of TRP53, yet it is notable that the embryos with highest
levels of expression where all from the same couple.
As a consequence of Australian government legislative
requirements, it was only possible to examine TRP53
expression in embryos that had first been cryopreserved.
This study cannot, therefore, exclude the possibility that
some of the variability in TRP53 expression was a conse-
quence of cryopreservation. This seems unlikely since the
embryos were fixed immediately upon thawing, and cool-
ing would seem to militate against increase protein syn-
thesis. It is clear that cryopreservation itself was not the
cause of increased TRP53 expression since some embryos
showed little TRP53 expression despite their cryopreserva-
tion. However, we can not exclude this possibility that it
contributed to the expression in some embryos, and since
this variable could not be controlled for in this study it is
important its potential effects be further assessed in juris-
dictions that are not so constrained in their use of
embryos for research purposes.
Conclusion
This study shows that some human embryos produced by
ICSI and subjected to prolonged culture express the
tumour suppressor protein, TRP53. The high degree of
variable expressivity of this protein shows that there is
considerable variability in the responsiveness of embryos,
and some cells within embryos, to the various stressors of
ICSI and culture. The study confirms the negative associa-
tion between the expression of TRP53 and embryo devel-
opment. The results indicate that in the human embryo,
expression of TRP53 may be one of the conditions that
determine the viability and developmental potential of
the embryo, as is the case in the mouse.
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